Kronox Lab Sciences Ltd

Kronox Lab Sciences Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda item is the consideration and approval of the Unaudited Standalone Financial Results for the quarter and half-year ended September 30, 2026. Concurrently, the company has informed that the trading window for its securities will remain closed for directors, officers, and designated employees from October 1, 2026, until 48 hours after the financial results are declared.

Kronox Lab Sciences Ltd has announced an amendment to a Share Purchase Agreement (SPA) originally executed on August 20, 2026. The amendment, dated October 22, 2026, modifies the SPA between Indo Borax and Chemicals Limited (Purchaser), Zenrock Chemicals Private Limited (ZCPL), and the erstwhile promoters (Sellers: Mr. Ketan Vinodchandra Ramani, Mr. Pritesh Vinodchandra Ramani, Mr. Jogindersingh Gianchand Jaswal). The Company is not a direct party to this agreement. Key changes include the deletion of Clause 9.5 (Lock-in on Sellers' Shareholding) and Clause 9.6 (Right of First Refusal). Consequently, the Sellers' shares will no longer be subject to a lock-in period, and the Purchaser will not have a right of first refusal over any retained shares by the Sellers. Indo Borax and Chemicals Limited, along with ZCPL, became the promoter and promoter group respectively on September 29, 2026, acquiring 64.26% of the Company's equity. The Sellers collectively held 9.95% of the Company's share capital.

Kronox Lab Sciences Ltd has approved the acquisition of a 5000 Sq. meter plant located in Dahej SEZ from Axiom Chemicals Private Limited. This strategic acquisition aims to expand the company's manufacturing capacity to support business growth. The transaction, valued at a cash consideration plus related expenses, is expected to be completed within one month, subject to regulatory approvals. The acquired plant is in the chemicals industry, and the seller is not a related party. The acquisition will be funded through internal accruals.

Kronox Lab Sciences Ltd announced that its Board of Directors has approved the acquisition of a manufacturing plant located in Dahej Special Economic Zone. The plant, measuring approximately 5000 Sq. meters, is being acquired from Axiom Chemicals Private Limited. This strategic move aims to expand the company's manufacturing capacity for future growth. The acquisition will be funded through internal accruals via cash consideration. The transaction is expected to be completed within one month, subject to regulatory approvals and definitive agreements. Axiom Chemicals Private Limited is engaged in the chemicals business, and the acquired plant is also involved in chemical manufacturing.

Mr. Jogindersingh Jaswal, Chairman & Managing Director of Kronox Lab Sciences Ltd, has sold 97,96,400 equity shares, representing 23.09% of the company's total paid-up equity share capital. The transaction was an off-market sale executed on September 29, 2026, with a reported value of ₹12,30,000. Following this sale, his holding in the company has reduced to 85,66,400 shares, which constitutes 20.09% of the total paid-up equity share capital. This disclosure is made pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Pritesh Vinodchandra Ramani has sold 67,11,200 equity shares, representing 23.088% of the total paid-up equity share capital, in Kronox Lab Sciences Limited. The shares were sold to Indo Borax & Chemicals Limited via an off-market transaction on September 29, 2026, as per a Share Purchase Agreement dated August 20, 2026. Following this sale, Indo Borax & Chemicals Limited, along with its PAC Zenrock Chemicals Private Limited, has acquired the right to exercise 64.26% of the voting rights in Kronox Lab Sciences Limited and has become the promoter of the company. The total equity share capital of Kronox Lab Sciences Limited is valued at INR 37,10,40,000, comprising 3,71,04,000 equity shares of face value INR 10 each.

Jogindersingh Gianchand Jaswal, a seller in Kronox Lab Sciences Ltd, has sold 85,66,400 equity shares, representing 23.08% of the company's total paid-up equity share capital. The off-market sale was made to Indo Borax & Chemicals Limited and Zenrock Chemicals Private Limited (PAC) pursuant to a Share Purchase Agreement dated August 20, 2026. Prior to this transaction, the seller held 97,96,400 shares (26.40%). Following the sale, the seller's holding in Kronox Lab Sciences Ltd stands at 12,30,000 shares, which constitutes 3.32% of the total share capital. This disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indo Borax & Chemicals Ltd, along with its PAC Zenrock Chemicals Private Limited, has acquired 85,66,400 equity shares in Kronox Lab Sciences Limited. This transaction represents a 23.088% stake in the company and was executed via an off-market sale for a total consideration of ₹37,10,40,000. Following this acquisition, Indo Borax & Chemicals Ltd has become the promoter of Kronox Lab Sciences Limited, gaining the right to exercise 64.26% of the voting rights. The seller in this transaction was Ketan Vinodchandra Ramani.

Indo Borax & Chemicals Limited, along with its PAC Zenrock Chemicals Private Limited, has acquired 2,38,44,000 equity shares in Kronox Lab Sciences Limited. This acquisition represents approximately 64.26% of the total paid-up equity share capital, making Indo Borax the new promoter of Kronox Lab Sciences. The transaction was an off-market purchase executed via a Share Purchase Agreement dated August 20, 2026. The total consideration for the acquisition was INR 37,10,40,000.

Indo Borax & Chemicals Limited, along with PAC Fontcck Chemicals Private Limited, has acquired a significant stake of 2,38,44,000 equity shares, representing 64.26% of the total share capital, in Kronox Lab Sciences Limited. The acquisition was executed through a Share Purchase Agreement dated August 20, 2026, with sellers Mr. Ketan Vinodchandra Ramani, Mr. Pritesh Vinodchandra Ramani, and Mr. Jogindersingh Gianchand Jaswal. This transaction is a substantial acquisition under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, and the disclosure has been made accordingly. The acquisition effectively transfers control of Kronox Lab Sciences to Indo Borax & Chemicals.